Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McKindler? New Pfizer CEO Echoes McKinnell’s Views On Payers, Scale

Executive Summary

Pfizer's success will depend on its ability to negotiate the paradox of increasing demand for pharmaceuticals coupled with growing attempts to restrain costs, CEO Jeffrey Kindler said

You may also be interested in...



Payers Having More Impact On R&D, Pfizer Says; Asenapine Is Early Casualty

Pfizer's termination of its codevelopment agreement with Organon for the antipsychotic asenapine is indicative of the increasingly important role payer considerations play in development decisions, Pfizer CEO Jeffrey Kindler said

Payers Having More Impact On R&D, Pfizer Says; Asenapine Is Early Casualty

Pfizer's termination of its codevelopment agreement with Organon for the antipsychotic asenapine is indicative of the increasingly important role payer considerations play in development decisions, Pfizer CEO Jeffrey Kindler said

Pfizer Cost-Cutting: Details Are Sketchy, But Sales Force Is On The Table

Pfizer CEO Jeffrey Kindler has opened the door to sales force reductions as part of the firm's latest cost-cutting initiative, announced Oct. 1

Related Content

UsernamePublicRestriction

Register

ID1132356

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel